The percentages of pDCs expressing Ki67, CD86, and CD80, hallmarks of TLR-induced pDC activation (McKenna et al., 2005), were significantly increased in SLE patients with active disease compared to inactive patients or healthy controls (Figures 4B–4E). This evidence concerns the gene CD80 and systemic lupus erythematosus.